Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Abstract
OBJECTIVE: It has recently been suggested that autonomous cortisol production may lead to subclinical glucocorticoid excess in a substantial number of patients with incidentally discovered adrenocortical adenomas. Following a standard low-dose dexamethasone suppression test (LDDST) cortisol concentrations are frequently incompletely suppressed in patients with adrenal incidentalomas, due to an ACTH-independent secretion of cortisol by the adrenal mass. Thus, post LDDST cortisol concentrations may provide a measure of the degree of autonomous glucocorticoid secretion, but hormonal alterations in relation to post-LDDST cortisol concentrations have not been thoroughly investigated. PATIENTS AND MEASUREMENTS: 61 patients with radiological features highly suggestive of adrenal adenomas were studied. These included 43 women, 18 men; mean age 59 +/- 1.4, range: 25-76 years; BMI 30.9 +/- 0.8 kg/m2 and waist:hip ratio 0.90 +/- 0.016. All subjects underwent a standard LDDST, as follows: after a 48-hr stabilisation period, 24-hr urine collections for basal urinary free cortisol (UFC) were performed. Basal serum cortisol and plasma ACTH were measured at 8 AM and at midnight the following day, and subjects started dexamethasone 0.5 mg 6 hourly for 2 days. Post-dexamethasone cortisol and ACTH levels were measured at 8 AM, 6-hrs after the last dose of dexamethasone. Blood samples for dehydroepiandrosterone sulphate (DHEAS) and serum lipids were obtained on the morning preceding dexamethasone administration. RESULTS: Post-LDDST cortisol concentrations correlated positively with the size of the adenoma (r = +0.527, P < 0.001). There was a negative rank correlation of post-LDDST cortisol concentrations and basal ACTH levels at 0900 h (rs = -0.426, P < 0.001) and DHEAS (rs = -0.380, P = 0.006). Moreover, there was a good rank correlation between DHEAS and basal ACTH levels (rs = +0.456, P < 0.001). A positive rank correlation was observed between post-LDDST cortisol concentrations and midnight cortisol concentrations (rs = +0.317, P = 0.020). As recent studies have suggested that post-LDDST cortisol levels higher than 70 nmol/l may indicate significant hypercortisolism comparisons were also performed between patients divided according to post-LDDST cortisol values into 3 groups: Group A, > 70 nmol/l (19 pts); Group B, 30-70 nmol/l (27 pts); Group C, < 30 nmol/l (15 pts). Although there was no difference in basal cortisol and UFC values between these groups, ACTH and DHEAS levels were significantly lower, and midnight cortisol significantly higher in group A compared to group C patients (P = 0.030, P = 0.017 and P = 0.001 respectively). Cholesterol and triglyceride levels were slightly albeit significantly higher in group A compared to group C patients (P < 0.05). CONCLUSIONS: It is concluded that higher post-low dose dexamethasone cortisol concentrations are associated with lower ACTH and dehydroepiandrosterone sulphate, higher midnight cortisol concentrations and larger adenomas. These findings are consistent with the hypothesis that post-low dose dexamethasone cortisol concentrations represent a useful index in assessing subtle glucocorticoid autonomy in patients with adrenal adenomas.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In more than 25% of patients with adrenal incidentalomas, cortisol is not suppressed after 1-mg or 3-mg overnight dexamethasone suppression testing or 2-day low-dose dexamethasone suppression testing.
“In more than 25% of AI subjects, the lack of cortisol suppression after 1-or 3-mg overnight DST or 2-d low-dose DST (LDDST) (19,34,41,44,46,48,53,55,56,60,61)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [41]
Low-dose dexamethasone suppression testing has been used to diagnose subclinical hypercortisolism without advantages, except possibly in patients with alcoholism, psychiatric disorders, or diabetes.
“Similarly, LDDST has been used to diagnose SH (18,40,41,55) without advantages, with the exception of patients affected with alcoholism, psychiatric disorders, and diabetes in whom this test may be more accurate (1,14,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [41]
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869 · see citing works
Dehydroepiandrosterone (DHEA): a fountain of youth?
Baulieu, É.-É. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784058 · Cited by 367 · see citing works
Reincke, M., Nieke, J., Krestin, G. P., Saeger, W., Allolio, B., & Winkelmann, W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517373 · Cited by 346 · see citing works
Incidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 272 · see citing works
Serendipitous adrenal masses: Prevalence, significance, and management
Abecassls, M., Loughlin, M. J. M., Langer, B., & Kudlow, J. E. (1985) · The American Journal of Surgery · doi:10.1016/s0002-9610(85)80186-0 · Cited by 233 · see citing works
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell-Price, J. D. C., Trainer, P. J., Perry, L., Wass, J. A. H., Grossman, A. B., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 221 · see citing works
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206 · see citing works
Kasperlik‐Załuska, A. A., Rosłonowska, E., Słowińska‐Srzednicka, J., Migdalska, B., Jeske, W., Makowska, A., & Snochowska, H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1751.x · Cited by 155 · cited 1× · see citing works
“It has been suggested that, depending on the amount and the duration of cortisol excess, hormonal changes leading to lower ACTH and DHEAS levels and alterations of the diurnal rhythm may develop (Virkalla et al., 1989; Reincke et al., 1992; Osellaet al., 1994; Ambrosiet al., 1995; Flecchia et al., 1995; Kasperlik-Zalu…”
BackgroundThe diagnosis and differential diagnosis of Cushing's syndrome
Trainer, P. J., & Grossman, A. B. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03773.x · Cited by 155 · see citing works
Chidiac, R. M., & Aron, D. C. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70242-5 · Cited by 140 · see citing works
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136 · cited 2× · see citing works
“levels have also frequently been described in patients with adrenal incidentalomas and, in fact many authors have suggested that low DHEAS levels represent the most common abnormality in such patients (Osella et al., 1994; Ambrosi et al., 1995; Flecchiaet al., 1995).”
BackgroundAdrenal incidentalomas: a manifestation of the metabolic syndrome?
Reincke, M., Faßnacht, M., Väth, S., Mora, P., & Allolio, B. (1996) · Endocrine Research · doi:10.1080/07435809609043773 · Cited by 133 · see citing works
Clinical review 50: Clinically silent adrenal masses
Gross, M., & Shapiro, B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.4.8408461 · Cited by 106 · see citing works
Weber, A., Clark, A. J. L., Perry, L. A., Honour, J. W., & Savage, M. O. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1580969.x · Cited by 99 · see citing works
Adrenal Insufficiency After Operative Removal of Apparently Nonfunctioning Adrenal Adenomas
Huiras, C. M. (1989) · JAMA · doi:10.1001/jama.1989.03420060110042 · Cited by 84 · see citing works
Different patterns of steroid secretion in patients with adrenal incidentaloma
Terzolo, M., Osella, G., Alı̀, A., Borretta, G., Magro, G., Termine, A., Paccotti, P., & Angeli, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636297 · Cited by 76 · see citing works
Flecchla, D., Mazza, E., Carllni, M., Blatto, A., Ollvlerl, F., Serra:, G., Camannl, F., & Messlna, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01852.x · Cited by 75 · see citing works
Bardet, S., Rohmer, V., Murat, A., Guillemot, C., Maréchaud, R., Chupin, M., Lecomte, P., Simon, D., Delemer, B., Schneebelli, S., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.720541.x · Cited by 71 · see citing works
A-I-D-S: the new endocrine epidemic.
Griffing, G. T. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989451 · Cited by 65 · see citing works
Tsagarakis, S., Kokkoris, P., Roboti, C., Malagari, C., Kaskarelis, J., Vlassopoulou, V., Alevizaki, C. C., & Thalassinos, N. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00464.x · Cited by 63 · see citing works
Virkkala, A., Välimäki, M. J., Pelkonen, R., Huikuri, K., Kahri, A. I., Kivisaari, L., Korhonen, T., Salmi, J., & Seppälä, P. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210067 · Cited by 58 · see citing works
Bencsik, Z., Szabolcs, I., Kovács, Z., Ferencz, A., Vörös, A., Kaszás, I., Bor, K., Gönczi, J., Góth, M., Kovács, L., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626824 · Cited by 49 · see citing works
Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas
Lavoie, H. B., & Lacroix, A. (1995) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)00091-u · Cited by 37 · see citing works
A-I-D-S: the new endocrine epidemic
Griffing, G. T. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1530 · Cited by 34 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090 · see citing works
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642 · see citing works
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 519 · see citing works
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415 · see citing works
Occult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287 · see citing works
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285 · see citing works
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279 · see citing works
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 255 · see citing works
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179 · see citing works
Subclinical Cushing’s syndrome: definition and management
Terzolo, M., Pia, A., & Reimondo, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04253.x · Cited by 129 · see citing works
Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113 · see citing works
Self-citationHormonal activity of adrenal incidentalomas: results from a long-term follow-up study
Vassilatou, E., Vryonidou, A., Michalopoulou, S., Manolis, J., Caratzas, J., Phenekos, C., & Tzavara, I. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03492.x · Cited by 112 · see citing works
DIAGNOSIS AND MANAGEMENT OF ADRENAL INCIDENTALOMAS
Barzon, L., & Boscaro, M. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67888-3 · Cited by 111 · see citing works
Bernini, G., Moretti, A., Iacconi, P., Miccoli, P., Nami, R., Lucani, B., & Salvetti, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480213 · Cited by 105 · see citing works
Aron, D. C., & Howlett, T. A. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70124-9 · Cited by 90 · see citing works
Terzolo, M., Bovio, S., Pia, A., Conton, P. A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01959 · Cited by 89 · see citing works
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Mantero, F., & Arnaldi, G. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70119-5 · Cited by 83 · see citing works
Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli, N., Catargi, B., Ronci, N., Vergnot, V, Leccia, F., Ferriere, J., Chene, G., Grenier, N., Laurent, F., & Tabarin, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440401 · Cited by 83 · see citing works
“Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients
Mitchell, I. C., Auchus, R. J., Juneja, K., Chang, A. Y., Holt, S. A., Snyder, W. H., & Nwariaku, F. E. (2007) · Surgery · doi:10.1016/j.surg.2007.10.001 · Cited by 84 · see citing works
Subclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80 · see citing works
Subclinical Cushing's syndrome in adrenal incidentalomas
Sippel, R. S., & Chen, H. (2004) · Surgical Clinics of North America · doi:10.1016/j.suc.2004.01.001 · Cited by 72 · see citing works
Bone loss rate in adrenal incidentalomas: a longitudinal study
Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8022 · Cited by 69 · see citing works
Subclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A. R., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 67 · see citing works
Subclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 63 · see citing works
Vassiliadi, D. A., Ntali, G., Vicha, E., & Tsagarakis, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03963.x · Cited by 61 · see citing works
Olsen, H., Nordenström, E., Bergenfelz, A., Nyman, U., Valdemarsson, S., & Palmqvist, E. (2012) · Endocrine · doi:10.1007/s12020-012-9622-2 · Cited by 60 · see citing works
Hadjidakis, D., Tsagarakis, S., Roboti, C., Sfakianakis, M., Iconomidou, V., Raptis, S. A., & Thalassinos, N. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01676.x · Cited by 60 · see citing works
Debono, M., Chadarévian, R., Eastell, R., Ross, R. J. M., & Newell-Price, J. D. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060984 · Cited by 60 · see citing works
Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
Ness‐Abramof, R., Nabriski, D., Apovian, C. M., Niven, M., Weiss, E., Shapiro, M. S., & Shenkman, L. (2002) · Obesity Research · doi:10.1038/oby.2002.166 · Cited by 58 · see citing works
Fagour, C., Bardet, S., Rohmer, V., Arimone, Y., Lecomte, P., Valli, N., & Tabarin, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0299 · Cited by 58 · see citing works
The Adrenal Incidentaloma: Disease of Modern Technology and Public Health Problem
Aron, D. C. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011580819132 · Cited by 56 · see citing works
DHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous?
Yener, S., Yilmaz, H., Demir, T., Seçil, M., & Çömlekçi, A. (2014) · Endocrine · doi:10.1007/s12020-014-0387-7 · Cited by 55 · see citing works
Adrenal incidentalomas — a continuing management dilemma
Nawar, R., & Aron, D. C. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00951 · Cited by 56 · see citing works
Osella, G., Reimondo, G., Peretti, P., Alì, A., Paccotti, P., Angeli, A., & Terzolo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7178 · Cited by 54 · see citing works
Cardiovascular complications of mild autonomous cortisol secretion
Aresta, C., Favero, V., Morelli, V., Giovanelli, L., Parazzoli, C., Falchetti, A., Pugliese, F., Gennari, L., Vescini, F., Salcuni, A. S., et al. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101494 · Cited by 53 · see citing works
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 47 · see citing works
Tabarin, A., Espiard, S., Deutschbein, T., Amar, L., Vezzossi, D., Dalmazi, G. D., Reznik, Y., Young, J., Desailloud, R., Goichot, B., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00062-2 · Cited by 40 · see citing works
Endocrine incidentalomas—challenges imposed by incidentally discovered lesions
Vassiliadi, D. A., & Tsagarakis, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.92 · Cited by 37 · see citing works
Vassiliadi, D. A., Ntali, G., Stratigou, T., Adali, M., & Tsagarakis, S. (2011) · Endocrine · doi:10.1007/s12020-011-9490-1 · Cited by 36 · see citing works
Deutschbein, T., Unger, N., Hinrichs, J., Walz, M. K., Mann, K., & Petersenn, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0517 · Cited by 28 · see citing works
Current status and controversies in adrenal incidentalomas
Kaltsas, G., Chrisoulidou, A., Piaditis, G. P., Kassi, E. N., & Chrousos, G. P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.001 · Cited by 26 · see citing works
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23 · see citing works
Starker, L. F., Kunstman, J. W., & Carling, T. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.02.008 · Cited by 21 · see citing works
Hormonal activity in clinically silent adrenal incidentalomas
Babińska, A., Siekierska-Hellmann, M., Błaut, K., Lewczuk, A., Wiśniewski, P., Gnacińska, M., Obołończyk, Ł., Świątkowska−Stodulska, R., & Sworczak, K. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.27288 · Cited by 20 · see citing works
Adrenal incidentalomas and glucocorticoid autonomy
Aron, D. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00522.x · Cited by 20 · see citing works
Tzanela, M., Mantzou, A., Saltiki, K., Tampourlou, M., Kalogeris, N., Hadjidakis, D., Tsagarakis, S., & Alevizaki, M. K. (2012) · PubMed · doi:10.3275/7840 · Cited by 18 · see citing works
Huayllas, M. K. P., Netzel, B. C., Singh, R. J., & Kater, C. E. (2018) · Laboratory Medicine · doi:10.1093/labmed/lmy005 · Cited by 17 · see citing works
Subclinical Cushing’s Syndrome
Beuschlein, F., & Reincke, M. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_7 · Cited by 15 · see citing works
Vassiliadi, D. A., Tzanela, M., Tsatlidis, V., Margelou, E., Tampourlou, M., Mazarakis, N., Piaditis, G. P., & Tsagarakis, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1653 · Cited by 14 · see citing works
Approach to the Patient With Bilateral Adrenal Masses
Vassiliadi, D. A., Delivanis, D. A., Papalou, O., & Tsagarakis, S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae164 · Cited by 14 · see citing works
Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
Gao, C. J., Ding, L., Zhang, X., Yuan, M., Tang, S., Li, W., Ye, Y., Liu, M., & He, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1158573 · Cited by 12 · see citing works
Tzanela, M., Effremidis, G., Vassiliadi, D. A., Szabo, A., Gavalas, N. G., Valatsou, A., Botoula, E., & Thalassinos, N. C. (2007) · Endocrine · doi:10.1007/s12020-007-9028-8 · Cited by 10 · see citing works
Suzuki, S., Uchida, D., Koide, H., Tanaka, T., Noguchi, Y., Saitō, Y., & Tatsuno, I. (2008) · Peptides · doi:10.1016/j.peptides.2008.06.011 · Cited by 10 · see citing works
Παππά, Θ., Papanastasiou, L., Kaltsas, G., Markou, Α., Tsounas, P., Androulakis, I. I., Tsiavos, V., Zografos, G., Vamvakidis, K., Samara, C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2874 · Cited by 9 · see citing works
Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Bednarek-Tupikowska, G. (2013) · PubMed · Cited by 9 · see citing works
Subclinical Cushing's syndrome
Tsinberg, M., Liu, C., & Duh, Q. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23143 · Cited by 9 · see citing works
Angeli, A., Osella, G., Reimondo, G., & Terzolo, M. (2002) · KARGER eBooks · doi:10.1159/000061074 · Cited by 8 · see citing works
Mu, D., Xia, Q., Ma, Y., Wang, X., Gao, Y., Ma, X., Xie, S., Hou, L., Zhang, Q., Zhao, F., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.04.008 · Cited by 7 · see citing works
Thyroid function spectrum in Cushing’s syndrome
Yu, P., Yuan, H., Chen, H., & Li, X. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01614-4 · Cited by 7 · see citing works
Dluhy, R. G., Maher, M. M., & Wu, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcpc059002 · Cited by 5 · see citing works
Terzolo, M., Osella, G., Alı̀, A., & Angeli, A. (2000) · Endocrine updates · doi:10.1007/978-1-4615-4341-1_10 · Cited by 4 · see citing works
Diagnostic dilemmas in Cushing's syndrome
Davies, J. S., Ogunko, A., Smith, J. N., Russell, D., John, R. M., & Scanlon, M. F. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001901399 · Cited by 4 · see citing works
Subclinical hypercortisolism: debatable or visible on the lightbox?
Vassiliadi, D. A., & Tsagarakis, S. (2012) · Endocrine · doi:10.1007/s12020-012-9689-9 · Cited by 4 · see citing works
Tzanela, M., Zianni, D., Stylianidou, C., Karavitaki, N., Tsagarakis, S., & Thalassinos, N. C. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02266.x · Cited by 3 · see citing works
Tumores suprarrenales clínicamente asintomáticos (incidentalomas suprarrenales)
de Diego, J. S. (2001) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(01)74773-0 · Cited by 3 · see citing works
A Case of Subclinical Cushing Syndrome and Multiple Myeloma
Kebapclar, L., Yeşil, S., Bayraktar, F., Demir, T., r, Z. G. N., lu, N. A., & i, A. M. (2007) · The Endocrinologist · doi:10.1097/01.ten.0000260862.09309.43 · Cited by 2 · see citing works
Lifestyle and Anthropometric Parameters in Patients with Nonfunctional Adrenal Incidentalomas
Dagdemir, A. N. (2023) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2023.25 · Cited by 2 · see citing works
Παππά, Θ., Papanastasiou, L., Kaltsas, G., Markou, Α., Tsounas, P., Tsiavos, V., Dasou, A., Tsiama, V., Zografos, G., & Piaditis, G. P. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 1 · see citing works
Langer, P., Waldmann, J., & Rothmund, Μ. (2007) · Der Chirurg · doi:10.1007/s00104-007-1365-x · Cited by 1 · see citing works
Síndrome de Cushing subclínico
Salvador, J., gÓmez, F., & Santos, E. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74618-5 · Cited by 1 · see citing works
L'incidentalome surrénalien, étude du statut métabolique et de la fibrinolyse
Thebert, J. (2015) · HAL
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Therapy, I. (2013)
NONFONKSİYONE ADRENAL İNSİDENTALOMALARDA İNSULİN REZİSTANSI VE YENİ İNFLAMATUAR BELİRTEÇLER
Akgün, Z., Güngüneş, A., & Durmaz, Ş. A. (2019) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.611526
Adrenal insidentaloma’lı hastalarda klinik, biyokimyasal ve radyolojik retrospektif analiz
Eser, Z. E., Gen, R., Eser, K., Sezer, K., & Akbay, E. (2022) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.1109724
Eser, Z. E., Gen, R., Eser, K., Sezer, K., & Akbay, E. (2024) · Proceedings of Anticancer Research · doi:10.26689/par.v8i1.6105
- Authors
- Tsagarakis, S., Roboti, C., Kokkoris, P., Vasiliou, V., Alevizaki, C., & Thalassinos, N.
- Affiliations
- Evangelismos Hospital (GR)
- Corresponding author
- Tsagarakis, S.
- ORCID
- Vasiliou, V.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1998-08
- Volume
- 49
- Issue
- 2
- Pages
- 165-171
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1976129656
- Cited by
- 75
- References
- 24
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal incidentaloma, adrenal adenoma, autonomous cortisol secretion, low-dose dexamethasone suppression test, ACTH, dehydroepiandrosterone sulfate, hypothalamic-pituitary-adrenal axis, adenoma size, urinary free cortisol
- MeSH terms
- Adenoma, Adrenal Cortex Function Tests, Adrenal Cortex Neoplasms, Adrenocorticotropic Hormone, Adult, Aged, Dexamethasone, Female, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Lipids, Male, Middle Aged, Pituitary-Adrenal System, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review